@article{LimayeTodiShroffetal.2016,
  author    = {Dnyanesh Limaye and K. Todi and J. Shroff and A. Ramaswamy and P. Kulkarni and Vaidehi Limaye and Gerhard Fortwengel},
  title     = {Cost-effectiveness Study of Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients From Mumbai, India},
  series   = {Current Therapeutic Research},
  volume    = {78},
  number    = {Supplement},
  doi       = {10.1016/j.curtheres.2016.05.006},
  url       = {http://nbn-resolving.de/urn:nbn:de:bsz:960-opus4-9151},
  pages     = {S2 -- S3},
  year      = {2016},
  abstract  = {Diabetes is fast gaining the status of a potential epidemic in India, with >62 million individuals currently diagnosed with the disease.1 India currently faces an uncertain future in relation to the potential burden that diabetes may impose on the country. An estimated US\$ 2.2 billion would be needed to sufficiently treat all cases of type 2 diabetes mellitus (T2DM) in India.2 Many interventions can reduce the burden of this disease. However, health care resources are limited; thus, interventions for diabetes treatment should be prioritized.},
  language  = {en}
}